B- PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
ENROLLING
Trial ID:
NCT04775550 Protocol # :
21-007
Phase
II
Disease Sites
Multiple Myeloma
Principal Investigator
Nadeem, Omar
Site Research Nurses
Amweg, Laura, N.
Barrell, Anna
Brule, Maurice, N.
Davie, Christine, M.
Donadio, Kristen
Fleming, Norah, Michelle
Freeman, Stefani, Danielle
Gentile, Alissa
Ginter, Lindsey
Hixon, Nicole, R.
Houghton, Nicole
Kosinski, Michelle
Metivier, Amada
Miles, Brandy
Quinn, Caroline
Ricciardi, Caroline
Silva, Wendy, Ann
Spillane, Kerry, L.
Tattersall, Alice, Emily
Ward, Mackenna
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-007
21-007